HumImmu

HumImmu is a specialized biotechnology company that provides advanced humanized mouse models for preclinical drug discovery and development. The company utilizes a proprietary platform to engraft human immune cells and tissues into immunodeficient mice, creating a functional human immune system (HIS) within the animal. This technology enables researchers to evaluate the efficacy and safety of immunotherapies, vaccines, and biologics in a context that closely mimics human biology. HumImmu offers contract research services to pharmaceutical and biotech companies, focusing on therapeutic areas such as oncology, inflammation, and infectious diseases. By providing more predictive animal models, the company aims to reduce the risk of clinical trial failure and accelerate the delivery of new treatments to patients.